1. Home
  2. DOGZ vs SAVA Comparison

DOGZ vs SAVA Comparison

Compare DOGZ & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOGZ
  • SAVA
  • Stock Information
  • Founded
  • DOGZ 2003
  • SAVA 1998
  • Country
  • DOGZ China
  • SAVA United States
  • Employees
  • DOGZ N/A
  • SAVA N/A
  • Industry
  • DOGZ Miscellaneous manufacturing industries
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOGZ Consumer Discretionary
  • SAVA Health Care
  • Exchange
  • DOGZ Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • DOGZ 156.9M
  • SAVA 157.5M
  • IPO Year
  • DOGZ 2017
  • SAVA N/A
  • Fundamental
  • Price
  • DOGZ $11.90
  • SAVA $3.39
  • Analyst Decision
  • DOGZ
  • SAVA Buy
  • Analyst Count
  • DOGZ 0
  • SAVA 2
  • Target Price
  • DOGZ N/A
  • SAVA $5.00
  • AVG Volume (30 Days)
  • DOGZ 101.3K
  • SAVA 1.1M
  • Earning Date
  • DOGZ 10-17-2025
  • SAVA 11-12-2025
  • Dividend Yield
  • DOGZ N/A
  • SAVA N/A
  • EPS Growth
  • DOGZ N/A
  • SAVA N/A
  • EPS
  • DOGZ N/A
  • SAVA N/A
  • Revenue
  • DOGZ $20,707,707.00
  • SAVA N/A
  • Revenue This Year
  • DOGZ N/A
  • SAVA N/A
  • Revenue Next Year
  • DOGZ N/A
  • SAVA N/A
  • P/E Ratio
  • DOGZ N/A
  • SAVA N/A
  • Revenue Growth
  • DOGZ 39.47
  • SAVA N/A
  • 52 Week Low
  • DOGZ $6.81
  • SAVA $1.15
  • 52 Week High
  • DOGZ $56.02
  • SAVA $4.98
  • Technical
  • Relative Strength Index (RSI)
  • DOGZ 51.29
  • SAVA 57.01
  • Support Level
  • DOGZ $11.05
  • SAVA $2.61
  • Resistance Level
  • DOGZ $11.69
  • SAVA $3.05
  • Average True Range (ATR)
  • DOGZ 0.64
  • SAVA 0.23
  • MACD
  • DOGZ 0.11
  • SAVA 0.04
  • Stochastic Oscillator
  • DOGZ 89.47
  • SAVA 92.31

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: